<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN""http://www.w3.org/TR/html4/loose.dtd"><html><head><title>Norsk legemiddelhï¿½ndbok</title><LINK rel="stylesheet" href="css/stylesheet.css"><script type="text/javascript" src="lib/tableruler.js"></script>
<script type="text/javascript">
window.onload=function(){tableruler();}</script>
</head><body><p class = "gruppenavn">R06AD01_1, Alimemazin -  Tablett øsning </p><p class = "berettigetbruk">Refusjonsberettiget bruk:</p><p class = "bruk">Pruritus ved forskjellige dermatologiske lidelser. Palliativ behandling i livets sluttfase.</p><table class = "hoved" border = "0"><tr><td valign = "top"><p class = "refkode">Refusjonskode:</p><table class = "Tabell-A"><tr><th>ICPC</th><th>Beskrivelse</th><th>Vilkï¿½r nr.</th></tr><tbody><tr><td>-30</td><td>Annen langvarig og alvorlig hudsykdom</td><td>-  </td></tr><tr><td>-90</td><td>Palliativ behandling i livets sluttfase</td><td>136  </td></tr><tr><td>S86</td><td>Seboréisk dermatitt</td><td>-  </td></tr><tr><td>S87</td><td>Atopisk dermatitt/eksem</td><td>-  </td></tr><tr><td>S88</td><td>Kontakt-/allergisk dermatitt IKA</td><td>-  </td></tr><tr><td>S89</td><td>Bleiedermatitt</td><td>-  </td></tr><tr><td>S91</td><td>Psoriasis</td><td>-  </td></tr><tr><td>S98</td><td>Urticaria</td><td>-  </td></tr><tr><td>S99</td><td>Hud/underhud sykdom IKA</td><td>-  </td></tr></tbody></table></td><td valign = "top"><p class = "refkode">Refusjonskode:</p><table class = "Tabell-A"><tr><th>ICD</th><th>Beskrivelse</th><th>Vilkï¿½r nr.</th></tr><tbody><tr><td>-30</td><td>Annen langvarig og alvorlig hudsykdom</td><td>-  </td></tr><tr><td>-90</td><td>Palliativ behandling i livets sluttfase</td><td>136  </td></tr><tr><td>L20</td><td>Atopisk dermatitt</td><td>-  </td></tr><tr><td>L21</td><td>Seboréisk dermatitt</td><td>-  </td></tr><tr><td>L22</td><td>Bleiedermatitt</td><td>-  </td></tr><tr><td>L23</td><td>Allergisk kontaktdermatitt</td><td>-  </td></tr><tr><td>L24</td><td>Toksisk kontaktdermatitt</td><td>-  </td></tr><tr><td>L40</td><td>Psoriasis</td><td>-  </td></tr><tr><td>L50</td><td>Urticaria</td><td>-  </td></tr></tbody></table></tr><tr colspan = "2"><td colspan = "2"><table class = "Tabell-A"><tr><td>Vilkï¿½r</td></tr><tr><td valign = "top">136</td><td>Refusjon ytes selv om legemidlet skal brukes i mindre enn tre måneder.</td></tr></table></td></tr></table><p class = "berettigetbruk">Refusjonsberettigede preparater:</p><ul><li>Vallergan Tab 10 mg 25stykk<i> - Blisterpakning</i></li><li>Vallergan Mikst 5 mg/ml 150milliliter<i> - Flaske</i></li></ul><br><br><br><center><input type="button" value="Lukk vindu" onclick="window.close()"></center><br></body></html>